Therapy News and Research

RSS

Outsiders swoop in vowing to rescue rural hospitals short on hope — and money

Beau Gertz faced a crowd of worried locals at this town's senior center, hoping to sell them on his vision for their long-beloved — but now bankrupt — hospital.

4 Jun 2018

Researchers use magnets to control tiny DNA-based robots

Researchers have devised a magnetic control system to make tiny DNA-based robots move on demand - and much faster than recently possible.

4 Jun 2018

Researchers identify racial differences in breast cancer immune microenvironment

Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes.

4 Jun 2018

Bubble pop? Brownie batter? Vapes’ added flavors fuel e-cig debate

A heated debate is redrawing alliances in the tobacco control movement as federal officials wrestle with how to regulate the growing e-cigarette market.

4 Jun 2018

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.

4 Jun 2018

African-American men with prostate cancer show stronger response to hormone therapy

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers.

4 Jun 2018

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.

1 Jun 2018

Study finds women experiencing menopause symptoms even in their 70s and 80s

Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.

1 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Serotonin stimulation may improve patience, mice study shows

Just a little longer. It's a common experience: hanging on in the hopes that our patience will pay off in the end.

1 Jun 2018

Research project offers hope for pediatric patients with thalassemia

Children born with thalassaemia, a genetic blood disease, cannot create normal haemoglobin, which is needed to produce healthy red blood cells. Regular blood transfusions are the only treatment available, but iron overload is inevitable.

1 Jun 2018

Screening preemies for microRNA biomarkers may allow early intervention of cerebral palsy

As the first step toward predicting cerebral palsy in premature infants, scientists have identified a panel of microRNAs that are changed in babies who later develop abnormal muscle tone.

1 Jun 2018

ORNL increases production of actinium-227 to meet demand for cancer drug

The Department of Energy's Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

1 Jun 2018

Regular mental health checkups may be better way to treat anxiety

No matter which treatment they get, only 20 percent of young people diagnosed with anxiety will stay well over the long term, UConn Health researchers report in the Journal of the American Academy of Child and Adolescent Psychiatry.

1 Jun 2018

Salk researchers discover molecule that destroys key HIV protein

One of the many challenges in treating HIV is that the virus can lie dormant in cells, quietly evading immune detection until it suddenly roars to life without warning and begins replicating furiously.

1 Jun 2018

Cancer cells can use lipid molecules as fuel for growth, shows study

Cancer cells can when the blood supply is low use lipid molecules as fuel instead of blood glucose. This has been shown in animal tumor models by researchers at Karolinska Institutet in Sweden in a study published in Cell Metabolism.

1 Jun 2018

Study finds reciprocal link between emotional distress and treatment side effects of prostate cancer

A new study published in the Journal of Urology® reports that men with prostate cancer who had worse urinary, bowel, and sexual function after surgery or radiotherapy than others experienced more emotional distress. Interestingly, the reverse was also true as experiencing more distress led to worse function.

1 Jun 2018

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.

31 May 2018

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.

31 May 2018

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world.

31 May 2018

Therapy News and Research

Outsiders swoop in vowing to rescue rural hospitals short on hope — and money

Researchers use magnets to control tiny DNA-based robots

Researchers identify racial differences in breast cancer immune microenvironment

Bubble pop? Brownie batter? Vapes’ added flavors fuel e-cig debate

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

African-American men with prostate cancer show stronger response to hormone therapy

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Study finds women experiencing menopause symptoms even in their 70s and 80s

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Serotonin stimulation may improve patience, mice study shows

Research project offers hope for pediatric patients with thalassemia

Screening preemies for microRNA biomarkers may allow early intervention of cerebral palsy

ORNL increases production of actinium-227 to meet demand for cancer drug

Regular mental health checkups may be better way to treat anxiety

Salk researchers discover molecule that destroys key HIV protein

Cancer cells can use lipid molecules as fuel for growth, shows study

Study finds reciprocal link between emotional distress and treatment side effects of prostate cancer

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News